SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Deferred Costs, Current
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Deferred Costs, Current of $101.65 thousand as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredCostsCurrent · last filed 2024-11-13
- 2024-09-30: Deferred Costs, Current $101.65K.
| Period end | Deferred Costs, Current |
|---|---|
| 2024-09-30 | $101.65K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |